Houston-based cell therapy company FibroBiologics files to go public


Houston-based cell therapy company FibroBiologics has filed for a direct listing on the Nasdaq Global Market after previously putting off going public.

Previous Bank of America awards grants to two Pittsburgh nonprofits through Neighborhood Builders program
Next Norton Healthcare data breach affected more than 2 million people